Nariman Nezami, MD

Dr. Nezami received his MD from Islamic Azad University, Tabriz Branch in Tabriz, Iran. He completed his residency at Yale University School of Medicine in New Haven, Connecticut. He completed his fellowship in interventional radiology and postdoctoral training in biomedical engineering at Johns Hopkins School of Medicine in Baltimore, Maryland.

An interventional radiologist, Dr. Nezami specializes in percutaneous and transarterial interventions and imaging with a focus on interventional immunology and oncology procedures. He coordinates care with oncologists to treat patients with liver cancer, hepatocellular carcinoma, lung cancer, renal cancer and bone cancer as well as portal hypertension, deep venous thrombosis and associated complications.

Prior to joining University of Maryland School of Medicine, he practiced interventional radiology at Johns Hopkins School of Medicine in Baltimore, Maryland and Emory University in Atlanta, Georgia.

Dr. Nezami holds professional memberships with Society of Interventional Oncology, Society of Interventional Radiology, American College of Radiology, Radiology Society of North America and European Society of Radiology.

transarterial or percutaneous oncology procedures including radioembolization, drug eluding beads, or chemoembolization; locoregional therapies with immunotherapies or chemotherapies for liver, renal, and lung cancers.

Dr. Nezami has published a number of peer-reviewed original papers and reviews in leading scientific journals. He is Associate Editor for RSNA Case Collection.

Nezami N, Peters G, Moon JT, Kokabi N, Shaikh J, Majdalany BS. Laser Ablation of the Cystic Duct Followed with Cryoablation of Gallbladder: Leave Nothing Behind. J Vasc Interv Radiol. 2021 Jul 19:S1051-0443(21)01217-3. doi: 10.1016/j.jvir.2021.07.006. Epub ahead of print. PMID: 34293436.

Rexha I, Laage-Gaupp F, Chapiro J, Miszczuk MA, van Breugel JMM, Lin M, Konstantinidis M, Duran R, Gebauer B, Georgiades C, Hong K, Nezami N. Role of 3D quantitative tumor analysis for predicting overall survival after conventional chemoembolization of intrahepatic cholangiocarcinoma. Sci Rep. 2021 Apr 29;11(1):9337. doi: 10.1038/s41598-021-88426-x. PMID: 33927226; PMCID: PMC8085245.

Nezami N, Chockalingam A, Cornman-Homonoff J, Marino A, Pollak J, Mojibian H. Mechanical thrombectomy for pulmonary embolism in patients with patent foramen Ovale. CVIR Endovasc. 2020 Nov 28;3(1):89. doi: 10.1186/s42155-020-00180-9. PMID: 33247349; PMCID: PMC7695793.